Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Thalidomide MeSH Descriptor Data 2026


MeSH Heading
Thalidomide
Tree Number(s)
D02.241.223.805.810.800
D03.383.621.808.800
D03.633.100.513.750.750
Unique ID
D013792
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D013792
Scope Note
A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
Entry Term(s)
Sedoval
Thalomid
Pharm Action
Immunosuppressive Agents
Leprostatic Agents
Teratogens
Angiogenesis Inhibitors
Registry Numbers
4Z8R6ORS6L
0
Related Numbers
50-35-1
CAS Type 1 Name
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-
Date Introduced
1966/01/01
Last Updated
2017/05/24
Thalidomide Preferred
Sedoval Narrower
Thalomid Narrower
page delivered in 0.147s